Overcoming Translational Roadblocks to Accelerate Allogeneic Therapies to Clinic

Time: 12:15 pm
day: Conference Day Two Pink Track

Details:

• Identify current roadblocks in the progression of allogeneic therapies to clinic
• Share actionable strategies to overcome translational and regulatory hurdles
• Highlight Atara Biotherapeutics’ ATA3219 targeting lupus to inform the next steps toward market readiness

Speakers:

Jim Sesic Jim Sesic, is a seasoned regulatory executive with over 20 years of experience across the pharmaceutical, biotech, and cell and gene therapy sectors. As Head Read more